1. Winters A, Judy R, Chahal CAA, et al. Evidence of variations in genetic prevalence for loss-of-function PKP2 variants between individuals with European and African ancestry. Genetics in Medicine Open. 2026;4:104397. doi:10.1016/j.gimo.2026.104397
2. Carruth ED, Wang W, Van Syoc E, et al. Genome-First Arrhythmogenic Right Ventricular Cardiomyopathy Penetrance Is Not Correlated With Lifetime Exercise History. JACC: Advances. 2026;5(1):102464. doi:10.1016/j.jacadv.2025.102464
3. Gasperetti A, Muller SA, Peretto G, et al. Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants. Circulation. 2025;152(14):978-989. doi:10.1161/CIRCULATIONAHA.125.073919
4. Lee DSM, Cardone KM, Zhang DY, et al. Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum. Nat Genet. 2025;57(4):829-838. doi:10.1038/s41588-025-02140-2
5. Carruth ED, Murray B, Tichnell C, et al. Predicted Risk of Ventricular Arrhythmias in a Genome-First Population With Genetic Risk for Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Arrhythm Electrophysiol. 2025;18:e013231. doi:10.1161/CIRCEP.124.013231
6. Park J, Levin MG, Zhang D, et al. Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3. JAMA Cardiol. November 2024. doi:10.1001/jamacardio.2024.3547
7. Gasperetti A, Carrick RT, Protonotarios A, et al. Clinical features and outcomes in carriers of pathogenic desmoplakin variants. Eur Heart J. 2024;46(4):362-376. doi:10.1093/eurheartj/ehae571
8. Carrick RT, Carruth ED, Gasperetti A, et al. Improved diagnosis of arrhythmogenic right ventricular cardiomyopathy using electrocardiographic deep learning. Heart Rhythm. 2024;22:P1080-1088. doi:10.1016/j.hrthm.2024.08.030
9. Carrick RT, Gasperetti A, Protonotarios A, et al. A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers. Eur Heart J. July 2024. doi:10.1093/eurheartj/ehae409
10. Carruth ED, Qureshi M, Alsaid A, et al. Loss-of-Function FLNC Variants Are Associated With Arrhythmogenic Cardiomyopathy Phenotypes When Identified Through Exome Sequencing of a General Clinical Population. Circ Genom Precis Med. 2022;15:e003645. doi:10.1161/CIRCGEN.121.003645
11. Carruth ED, Fielden SW, Nevius CD, Fornwalt BK, Haggerty CM. 3D-Encoded DENSE MRI with Zonal Excitation for Quantifying Biventricular Myocardial Strain During a Breath-Hold. Cardiovasc Eng Technol. July 2021:1-9. doi:10.1007/s13239-021-00561-8
12. Carruth ED, Beer D, Alsaid A, et al. Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants. Circ Genom Precis Med. 2021;14(2):201-212. doi:10.1161/CIRCGEN.120.003302
13. Carruth ED, Young W, Beer D, et al. Prevalence and Electronic Health Record-Based Phenotype of Loss-of-Function Genetic Variants in Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Genes. Circ Genom Precis Med. 2019;12(11):487-494. doi:10.1161/CIRCGEN.119.002579